Lv1
60 积分 2024-09-24 加入
Therapeutic opportunities for the treatment of NASH with genetically validated targets
8天前
已完结
Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
13天前
已完结
Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a)
20天前
已完结
Personalized Medicine for Dyslipidemias by RNA Interference-Mediated Reductions in Apolipoprotein C3 or Angiopoietin-Like Protein 3
1个月前
已完结
Systemic siRNA delivery via hydrodynamic intravascular injection
1个月前
已完结
Functional Comparison of Interferon‐α Subtypes Reveals Potent Hepatitis B Virus Suppression by a Concerted Action of Interferon‐α and Interferon‐γ Signaling
1个月前
已完结
Megalin Blockade with Cilastatin Suppresses Drug-Induced Nephrotoxicity
1个月前
已完结
β- and γ-Interferon in Chronic Active Hepatitis B
1个月前
已完结
Liver-specific inactivation of Cideb improves metabolic profiles and ameliorates steatohepatitis and fibrosis in animal models for MASH
2个月前
已完结
TNF-α/IFN-γ profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection
2个月前
已完结
皖公网安备34019202002308
